233 related articles for article (PubMed ID: 15802167)
1. Antimicrobial treatment of community-acquired pneumonia.
Restrepo MI; Anzueto A
Clin Chest Med; 2005 Mar; 26(1):65-73. PubMed ID: 15802167
[TBL] [Abstract][Full Text] [Related]
2. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
[TBL] [Abstract][Full Text] [Related]
3. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
Niven DJ; Laupland KB
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
[TBL] [Abstract][Full Text] [Related]
4. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy.
Restrepo MI; Jorgensen JH; Mortensen EM; Anzueto A
Curr Opin Infect Dis; 2001 Dec; 14(6):703-9. PubMed ID: 11964888
[TBL] [Abstract][Full Text] [Related]
5. Community acquired bacterial pneumonia.
Anevlavis S; Bouros D
Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
[TBL] [Abstract][Full Text] [Related]
6. Short-course antimicrobial therapy for community-acquired pneumonia.
Kolditz M; Halank M; Höffken G
Treat Respir Med; 2005; 4(4):231-9. PubMed ID: 16086597
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial therapy of community-acquired pneumonia.
File TM; Niederman MS
Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
[TBL] [Abstract][Full Text] [Related]
8. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed?
Cunha BA
Chest; 2004 May; 125(5):1913-9. PubMed ID: 15136407
[TBL] [Abstract][Full Text] [Related]
9. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
10. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.
Stahl JE; Barza M; DesJardin J; Martin R; Eckman MH
Arch Intern Med; 1999 Nov; 159(21):2576-80. PubMed ID: 10573047
[TBL] [Abstract][Full Text] [Related]
11. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
Mortensen EM; Restrepo MI; Anzueto A; Pugh J
Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
[TBL] [Abstract][Full Text] [Related]
12. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.
Dedier J; Singer DE; Chang Y; Moore M; Atlas SJ
Arch Intern Med; 2001 Sep; 161(17):2099-104. PubMed ID: 11570938
[TBL] [Abstract][Full Text] [Related]
13. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
14. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
Esposito S; Fiore M
Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
[No Abstract] [Full Text] [Related]
15. Antibiotic stewardship in community-acquired pneumonia.
Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
Zervos M; Mandell LA; Vrooman PS; Andrews CP; McIvor A; Abdulla RH; de Caprariis PJ; Knirsch CA; Amsden GW; Niederman MS; Lode H
Treat Respir Med; 2004; 3(5):329-36. PubMed ID: 15606222
[TBL] [Abstract][Full Text] [Related]
17. Principles of Antibiotic Management of Community-Acquired Pneumonia.
Bender MT; Niederman MS
Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214
[TBL] [Abstract][Full Text] [Related]
18. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.
El Moussaoui R; Opmeer BC; de Borgie CA; Nieuwkerk P; Bossuyt PM; Speelman P; Prins JM
Chest; 2006 Oct; 130(4):1165-72. PubMed ID: 17035452
[TBL] [Abstract][Full Text] [Related]
19. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
[TBL] [Abstract][Full Text] [Related]
20. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ
Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
